Whole body insulin resistance in myotonic dystrophy
- PMID: 6367619
- DOI: 10.1002/ana.410150208
Whole body insulin resistance in myotonic dystrophy
Abstract
To quantitate the degree of whole body insulin resistance in patients with myotonic dystrophy, three separate euglycemic insulin infusions were given to ambulatory patients and the results compared with findings in normal control subjects. Basal glucose and insulin values were similar for the two groups. There was no significant difference in insulin clearance rates between normal subjects and patients at the three insulin infusion rates used. A highly significant decrease in the whole body glucose disposal rate was seen during the 120-minute insulin infusion in the patients with myotonic dystrophy compared with normal subjects at all three insulin dosages (20 mU/m2/min: 2.18 +/- 0.29 [standard error] versus 5.49 +/- 1.72 mg/kg/min, p less than 0.0001; 80 mU/m2/min: 4.16 +/- 0.34 versus 8.49 +/- 0.45 mg/kg/min, p less than 0.0001; 200 mU/m2/min: 5.22 +/- 0.53 versus 10.06 +/- 0.50 mg/kg/min, p less than 0.0001). These marked decreases in glucose disposal rates for the patients were adjusted in accordance with their 24-hour urinary creatinine excretion rate to correct for the difference in muscle mass between patients and controls. This adjusted glucose disposal rate was 15 to 25% lower (p less than 0.02) in the patients with myotonic dystrophy at insulin infusion rates of 20 and 80 mU. During the 200 mU insulin infusions, the adjusted glucose disposal rate remained lower than that in normal subjects but was of borderline statistical significance. These studies suggest that moderately severe whole body insulin resistance is responsible for the postprandial hyperinsulinemia typically seen in patients with myotonic dystrophy.
Similar articles
-
Decreased insulin sensitivity of forearm muscle in myotonic dystrophy.J Clin Invest. 1978 Oct;62(4):857-67. doi: 10.1172/JCI109198. J Clin Invest. 1978. PMID: 701484 Free PMC article.
-
Insulin resistance and regulation of serum amino acid levels in myotonic dystrophy.Clin Sci (Lond). 1986 Oct;71(4):429-36. doi: 10.1042/cs0710429. Clin Sci (Lond). 1986. PMID: 3530612 Clinical Trial.
-
Contrasting effects of L-arginine on insulin-mediated blood flow and glucose disposal in the elderly.Metabolism. 2001 Feb;50(2):194-9. doi: 10.1053/meta.2001.20182. Metabolism. 2001. PMID: 11229429
-
The disposal of intravenous glucose studied using glucose and insulin clamp techniques in sepsis and trauma in man.Acta Anaesthesiol Belg. 1987;38(4):275-9. Acta Anaesthesiol Belg. 1987. PMID: 3327334 Review.
-
[Myotonic dystrophy].Nihon Rinsho. 1998 Jan;56 Suppl 3:610-5. Nihon Rinsho. 1998. PMID: 9513486 Review. Japanese. No abstract available.
Cited by
-
Role of myotonic dystrophy protein kinase (DMPK) in glucose homeostasis and muscle insulin action.PLoS One. 2007 Nov 7;2(11):e1134. doi: 10.1371/journal.pone.0001134. PLoS One. 2007. PMID: 17987120 Free PMC article.
-
Non-Alcoholic Steatohepatitis in Myotonic Dystrophy: DMPK Gene Mutation, Insulin Resistance and Development of Steatohepatitis.Case Rep Gastroenterol. 2010 Mar 17;4(1):100-103. doi: 10.1159/000292093. Case Rep Gastroenterol. 2010. PMID: 21103235 Free PMC article.
-
Study on growth hormone and insulin secretion in myotonic dystrophy.Clin Investig. 1994 Jul;72(7):508-11. doi: 10.1007/BF00207479. Clin Investig. 1994. PMID: 7981578 Clinical Trial.
-
Myotonic Dystrophy and Developmental Regulation of RNA Processing.Compr Physiol. 2018 Mar 25;8(2):509-553. doi: 10.1002/cphy.c170002. Compr Physiol. 2018. PMID: 29687899 Free PMC article. Review.
-
Skeletal muscle disorders as risk factors for type 2 diabetes.Mol Cell Endocrinol. 2025 Apr 1;599:112466. doi: 10.1016/j.mce.2025.112466. Epub 2025 Jan 21. Mol Cell Endocrinol. 2025. PMID: 39848431 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials